These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16706961

  • 1. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
    Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M.
    J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
    [Abstract] [Full Text] [Related]

  • 2. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ, PREVENT Investigators.
    N Engl J Med; 2003 Apr 10; 348(15):1425-34. PubMed ID: 12601075
    [Abstract] [Full Text] [Related]

  • 3. Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
    Kamphuisen PW.
    J Thromb Haemost; 2006 Jun 10; 4(6):1206-7. PubMed ID: 16706960
    [No Abstract] [Full Text] [Related]

  • 4. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
    Tullett J, Murray E, Nichols L, Holder R, Lester W, Rose P, Hobbs FD, Fitzmaurice D.
    BMC Cardiovasc Disord; 2013 Mar 09; 13():16. PubMed ID: 23497371
    [Abstract] [Full Text] [Related]

  • 5. D-dimer levels and risk of recurrent venous thromboembolism.
    Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA.
    JAMA; 2003 Aug 27; 290(8):1071-4. PubMed ID: 12941680
    [Abstract] [Full Text] [Related]

  • 6. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G, PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics).
    Eur J Vasc Endovasc Surg; 2010 Mar 27; 39(3):356-65. PubMed ID: 20034816
    [Abstract] [Full Text] [Related]

  • 7. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
    Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators.
    N Engl J Med; 2003 Aug 14; 349(7):631-9. PubMed ID: 12917299
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.
    Cheung KL, Zakai NA, Callas PW, Howard G, Mahmoodi BK, Peralta CA, Judd SE, Kurella Tamura M, Cushman M.
    J Thromb Haemost; 2018 Sep 14; 16(9):1743-1752. PubMed ID: 29984467
    [Abstract] [Full Text] [Related]

  • 9. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA.
    J Thromb Haemost; 2019 Jul 14; 17(7):1144-1152. PubMed ID: 31033194
    [Abstract] [Full Text] [Related]

  • 10. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E, Johnsen HS, Hansen JB, Braekkan SK.
    J Thromb Haemost; 2017 May 14; 15(5):917-924. PubMed ID: 28166605
    [Abstract] [Full Text] [Related]

  • 11. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
    Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, Mackinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, Ginsberg JS, ELATE Investigators.
    Blood; 2008 Dec 01; 112(12):4432-6. PubMed ID: 18791166
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.
    Circulation; 2003 Jul 22; 108(3):313-8. PubMed ID: 12847064
    [Abstract] [Full Text] [Related]

  • 13. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA, CATCH Investigators.
    JAMA; 2015 Aug 18; 314(7):677-686. PubMed ID: 26284719
    [Abstract] [Full Text] [Related]

  • 14. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B, Legnani C, Cini M, Favaretto E, Palareti G.
    Thromb Res; 2008 Aug 18; 122(5):610-7. PubMed ID: 18304616
    [Abstract] [Full Text] [Related]

  • 15. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S.
    Thromb Haemost; 2002 Jan 18; 87(1):7-12. PubMed ID: 11848459
    [Abstract] [Full Text] [Related]

  • 16. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL, Evans MA, Murphy BR, Nutescu EA, Schein JR, Bookhart BK.
    Curr Med Res Opin; 2015 Mar 18; 31(3):439-47. PubMed ID: 25495136
    [Abstract] [Full Text] [Related]

  • 17. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.
    Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S.
    J Thromb Haemost; 2005 May 18; 3(5):955-61. PubMed ID: 15869591
    [Abstract] [Full Text] [Related]

  • 18. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY, Wu N, Gulseth M, LaMori J, Bookhart BK, Boulanger L, Fields L, Schein J.
    J Manag Care Pharm; 2013 May 18; 19(4):291-301. PubMed ID: 23627575
    [Abstract] [Full Text] [Related]

  • 19. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.
    N Engl J Med; 1999 Mar 25; 340(12):901-7. PubMed ID: 10089183
    [Abstract] [Full Text] [Related]

  • 20. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.
    Ann Intern Med; 2010 Oct 19; 153(8):523-31. PubMed ID: 20956709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.